Tyvyt

Eli Lilly dumps Innovent's PD-1 after FDA rebuff, nixing high-profile Chinese cancer drug
Fierce Pharma
Thu, 12/1/22 - 07:03 pm
Eli Lilly
Innovent Biologics
Tyvyt
China
Eli Lilly, Innovent's PD-1 in troubled waters as FDA review, oncology chief's comments portend likely rejection
Fierce Pharma
Wed, 02/9/22 - 10:56 am
Eli Lilly
Innovent
Tyvyt
PD-1 inhibitors
WCLC: Lilly, Innovent tout Tyvyt front-line lung cancer win. Can it challenge Merck’s Keytruda?
Fierce Pharma
Sun, 08/9/20 - 11:14 pm
Eli Lilly
Innovent Biologics
China
non-small cell lung cancer
Tyvyt
Merck
Keytruda